Search hospitals > Arkansas > Little Rock
Woodland International Research Group
Claim this profileLittle Rock, Arkansas 72211
Global Leader in Schizophrenia
Global Leader in Depression
Conducts research for Major Depressive Disorder
Conducts research for Bipolar Disorder
Conducts research for Psychosis
104 reported clinical trials
2 medical researchers
Summary
Woodland International Research Group is a medical facility located in Little Rock, Arkansas. This center is recognized for care of Schizophrenia, Depression, Major Depressive Disorder, Bipolar Disorder, Psychosis and other specialties. Woodland International Research Group is involved with conducting 104 clinical trials across 76 conditions. There are 2 research doctors associated with this hospital, such as George Konis, MD and Konis.Top PIs
George Konis, MDWoodland International Research Group3 years of reported clinical research
Studies Schizophrenia
Studies Bunions
11 reported clinical trials
15 drugs studied
KonisWoodland International Research Group1 year of reported clinical research
Studies Postoperative Pain
1 reported clinical trial
1 drug studied
Clinical Trials running at Woodland International Research Group
Schizophrenia
Bunions
Migraine
Anxiety
Generalized Anxiety Disorder
Sickle Cell Anemia
Sickle Cell Disease
KarXT
for Schizophrenia
This trial tests the safety and tolerability of KarXT, a combination of two drugs, in schizophrenia patients who haven't responded well to their current treatments. KarXT aims to improve symptoms and manage side effects better than existing medications. KarXT (xanomeline plus trospium) is an emerging treatment for schizophrenia, showing promise in managing total, positive, and negative symptoms.
Recruiting2 awards Phase 35 criteria
KarXT
for Schizophrenia
This trial tests KarXT, a combination of two drugs, for people who haven't improved with their current treatment. KarXT aims to balance brain functions and reduce side effects. The study will look at improvements in health and daily life. KarXT has shown positive results in earlier tests.
Recruiting1 award Phase 321 criteria
Iclepertin
for Schizophrenia
This trial is testing a new medicine called iclepertin to see if it can help adults with schizophrenia improve their learning and memory. Participants will take either the medicine or a non-active substance while continuing their regular medication. Doctors will regularly check their mental abilities and overall health over several months.
Recruiting1 award Phase 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Woodland International Research Group?
Woodland International Research Group is a medical facility located in Little Rock, Arkansas. This center is recognized for care of Schizophrenia, Depression, Major Depressive Disorder, Bipolar Disorder, Psychosis and other specialties. Woodland International Research Group is involved with conducting 104 clinical trials across 76 conditions. There are 2 research doctors associated with this hospital, such as George Konis, MD and Konis.